(Total Views: 501)
Posted On: 04/15/2022 3:32:01 PM
Post# of 148938
Amarex knew exactly what was going on. They were experts with tons of FDA experience. We were in constant contact with them for IND's for Covid at this time.
"Germantown, MD, USA (April 02, 2020) – Since early March, Amarex has worked closely with its client CytoDyn Inc. to achieve U.S. FDA approval for the use of leronlimab (PRO 140), a monoclonal antibody product currently used as an Investigation New Drug (IND) in the treatment of HIV/AIDS, oncology and other disease indications, in the treatment of coronavirus disease 2019 (COVID-19). Leronlimab is a humanized IgG4 mAb that blocks the CCR5 receptor and appears to modulate immune cell trafficking to site of inflammation."
Amarex Contact:
Patrick J. Burke
Look at Mr. Burke's experience on Linkedin, he's an FDA expert. There is NO excuse here - from the outside it looks nefarious and the more discovery there is, the worse this gets and we are not talking here about proof beyond a reasonable doubt, it's not a criminal case.
"Germantown, MD, USA (April 02, 2020) – Since early March, Amarex has worked closely with its client CytoDyn Inc. to achieve U.S. FDA approval for the use of leronlimab (PRO 140), a monoclonal antibody product currently used as an Investigation New Drug (IND) in the treatment of HIV/AIDS, oncology and other disease indications, in the treatment of coronavirus disease 2019 (COVID-19). Leronlimab is a humanized IgG4 mAb that blocks the CCR5 receptor and appears to modulate immune cell trafficking to site of inflammation."
Amarex Contact:
Patrick J. Burke
Look at Mr. Burke's experience on Linkedin, he's an FDA expert. There is NO excuse here - from the outside it looks nefarious and the more discovery there is, the worse this gets and we are not talking here about proof beyond a reasonable doubt, it's not a criminal case.
(3)
(0)Scroll down for more posts ▼
